Research Article

Carvedilol-Afforded Protection against Daunorubicin-Induced Cardiomyopathic Rats In Vivo: Effects on Cardiac Fibrosis and Hypertrophy

Figure 1

(a) Hematoxylin and eosin staining of the cross-sectional tissue slices of hearts depicting interstitial edema, vacuolization, and degeneration of cardiac fibers (X200). (b) Hematoxylin and eosin staining of the cross-sectional tissue slices of hearts depicting cardiac hypertrophy (X400), (c) Azan-Mallory staining for fibrosis of the cross-sectional tissue slices of hearts. Fibrosis is indicated by the blue area as opposed to the red myocardium (X200). (d) Bar graph showing % fibrosis in each experimental group. Each bar represents mean ± S.E.M. Group control (C) age-matched normal rats; group DNR, DNR-treated rats administered with vehicle; group Carv, DNR-treated rats administered with carvedilol (30 mg/kg/day). 𝑃 < . 0 5 versus group Control; # 𝑃 < . 0 5 versus group DNR.
430549.fig.001a
(a)
430549.fig.001b
(b)
430549.fig.001c
(c)
430549.fig.001d
(d)